Autoimmune diseases occur when the immune system mistakenly attacks the body’s own healthy tissues, causing chronic inflammation and damage.
We aim to address the root cause of disease.
Our strategy for treating autoimmune and inflammatory diseases centers on restoring immune system balance using engineered regulatory T cells (Tregs), while minimizing complications seen with other therapeutic approaches.
Tregs act as sentinels, detecting and suppressing unwanted immune responses to help restore immune system balance.
Treg-based therapies offer multiple therapeutic benefits in a single treatment, addressing the complex and multifactorial nature of autoimmune and inflammatory diseases.
The Autoimmune Problem
Our Concept
Applying Treg’s natural abilities to modulate immune response and repair tissue damage to develop therapies that achieve durable disease control and long-term treatment options for patients.
Our Science
We are engineering Tregs to target the key antigens that trigger autoimmune and inflammatory diseases.
Manufacturing
Through our proprietary manufacturing process, we isolate, expand, and enhance Tregs from a patient’s own immune system to treat autoimmune and inflammatory diseases.
Publications
Our team has published numerous peer-reviewed papers.
Clinical Trials
We are evaluating our lead Treg product in clinical trials and advancing other products through research and towards the clinic.